Cargando…
_version_ 1783610311539949568
author Nicoś, Marcin
Wojas-Krawczyk, Kamila
Krawczyk, Paweł
Chmielewska, Izabela
Wojcik-Superczyńska, Magdalena
Reszka, Katarzyna
Kieszko, Robert
Góra-Florek, Anna
Dudek, Małgorzata
Świniuch, Daria
Papiewski, Wojciech
Całka, Paulina
Ciesielka, Marzanna
Ramlau, Rodryg
Milanowski, Janusz
author_facet Nicoś, Marcin
Wojas-Krawczyk, Kamila
Krawczyk, Paweł
Chmielewska, Izabela
Wojcik-Superczyńska, Magdalena
Reszka, Katarzyna
Kieszko, Robert
Góra-Florek, Anna
Dudek, Małgorzata
Świniuch, Daria
Papiewski, Wojciech
Całka, Paulina
Ciesielka, Marzanna
Ramlau, Rodryg
Milanowski, Janusz
author_sort Nicoś, Marcin
collection PubMed
description
format Online
Article
Text
id pubmed-7667428
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-76674282020-11-20 Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma Nicoś, Marcin Wojas-Krawczyk, Kamila Krawczyk, Paweł Chmielewska, Izabela Wojcik-Superczyńska, Magdalena Reszka, Katarzyna Kieszko, Robert Góra-Florek, Anna Dudek, Małgorzata Świniuch, Daria Papiewski, Wojciech Całka, Paulina Ciesielka, Marzanna Ramlau, Rodryg Milanowski, Janusz Arch Med Sci Letter to the Editor Termedia Publishing House 2019-11-03 /pmc/articles/PMC7667428/ /pubmed/33224359 http://dx.doi.org/10.5114/aoms.2019.89217 Text en Copyright: © 2019 Termedia & Banach http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Letter to the Editor
Nicoś, Marcin
Wojas-Krawczyk, Kamila
Krawczyk, Paweł
Chmielewska, Izabela
Wojcik-Superczyńska, Magdalena
Reszka, Katarzyna
Kieszko, Robert
Góra-Florek, Anna
Dudek, Małgorzata
Świniuch, Daria
Papiewski, Wojciech
Całka, Paulina
Ciesielka, Marzanna
Ramlau, Rodryg
Milanowski, Janusz
Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma
title Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma
title_full Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma
title_fullStr Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma
title_full_unstemmed Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma
title_short Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma
title_sort assessment of egfr gene mutations in circulating free dna in monitoring of response to egfr tyrosine kinase inhibitors in patients with lung adenocarcinoma
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667428/
https://www.ncbi.nlm.nih.gov/pubmed/33224359
http://dx.doi.org/10.5114/aoms.2019.89217
work_keys_str_mv AT nicosmarcin assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma
AT wojaskrawczykkamila assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma
AT krawczykpaweł assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma
AT chmielewskaizabela assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma
AT wojciksuperczynskamagdalena assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma
AT reszkakatarzyna assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma
AT kieszkorobert assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma
AT goraflorekanna assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma
AT dudekmałgorzata assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma
AT swiniuchdaria assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma
AT papiewskiwojciech assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma
AT całkapaulina assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma
AT ciesielkamarzanna assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma
AT ramlaurodryg assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma
AT milanowskijanusz assessmentofegfrgenemutationsincirculatingfreednainmonitoringofresponsetoegfrtyrosinekinaseinhibitorsinpatientswithlungadenocarcinoma